tranScrip Information

tranScrip is now part of TMC, a global pharma services company offering end-to-end drug development solutions, from early-phase consulting and clinical development to market access and drug commercialisation. Established in 2001, TMC operates across hubs in the UK, US and EU (Ireland) and through its vast network of global contractors in over 70 countries. The acquisition brings together two highly accomplished, multidisciplinary teams with a shared commitment to helping emerging biotech and pharma companies progress therapies from innovative science to patients. Together, we can better support you across the full product lifecycle — with broader regulatory, medical and scientific expertise, plus greater access to specialist subject-matter experts and increased capacity for complex programmes.